biphasic insulin aspart 30 Recently Published Documents

Type 2 Diabetes Treatment

PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.171 ◽

2020 ◽

Vol 22 ◽

pp. S33-S34

Author(s):

周. 黎 ◽

Q. Luo ◽

N. Zhou ◽

M. Hu

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Insulin Degludec ◽

Short Term ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial

Diabetes Therapy ◽

10.1007/s13300-020-00904-z ◽

2020 ◽

Vol 11 (10) ◽

pp. 2313-2328

Author(s):

Li Wang ◽

Xiangyang Liu ◽

Wenjuan Yang ◽

Jingbo Lai ◽

Xinwen Yu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Randomized Trial ◽

Insulin Aspart ◽

Glucose Variability ◽

Open Label ◽

Biphasic Insulin ◽

Metformin Monotherapy

PDB120 UNDERSTANDING PATIENTS' WILLINGNESS TO PAY (WTP) FOR BIPHASIC INSULIN ASPART 30/70 (BIASP30) IN A FLEXPEN® DEVICE OR USING A PENFILL® FOR TYPE 2 DIABETES (T2D) TREATMENT IN AN OUT-OF-POCKET PAYMENTS MARKET

Value in Health ◽

10.1016/j.jval.2019.04.667 ◽

2019 ◽

Vol 22 ◽

pp. S160

Author(s):

S. Murthy ◽

P. Aneja ◽

A. Asirvatham ◽

B. Ramabhat ◽

L.L. Nystrup Husemoen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Willingness To Pay ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Out Of Pocket Payments

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐target trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13703 ◽

2019 ◽

Vol 21 (7) ◽

pp. 1652-1660 ◽

Cited By ~ 2

Author(s):

Wenying Yang ◽

Jianhua Ma ◽

Tianpei Hong ◽

Ming Liu ◽

Heng Miao ◽

...

Keyword(s):

Insulin Aspart ◽

Phase Iii ◽

Treat To Target ◽

Efficacy And Safety ◽

Target Trial ◽

Chinese Adults ◽

Open Label ◽

Biphasic Insulin ◽

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.02.023 ◽

2019 ◽

Vol 150 ◽

pp. 158-166 ◽

Cited By ~ 1

Author(s):

Wenying Yang ◽

Canan Ersoy ◽

Guixia Wang ◽

Shandong Ye ◽

Jun Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Diabetes Obesity and Metabolism ◽

10.1111/dom.13454 ◽

2018 ◽

Vol 20 (12) ◽

pp. 2740-2747

Author(s):

Lixin Guo ◽

Li Chen ◽

Baocheng Chang ◽

Liyong Yang ◽

Yu Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Diabetes Patients

Insulin Degludec/Insulin Aspart (IDegAsp) Twice Daily (BID) vs. Biphasic Insulin Aspart 30 (BIAsp 30) BID—A Randomized Trial in Chinese Patients with Type 2 Diabetes

Diabetes ◽

10.2337/db18-91-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 91-LB

Author(s):

WENYING YANG ◽

JIANHUA MA ◽

TIANPEI HONG ◽

MING LIU ◽

HENG MIAO ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Insulin Aspart ◽

Insulin Degludec ◽

Chinese Patients ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes

Drugs in R&D ◽

10.1007/s40268-018-0228-x ◽

2018 ◽

Vol 18 (1) ◽

pp. 27-39 ◽

Cited By ~ 7

Author(s):

Andreas Liebl ◽

Viswanathan Mohan ◽

Wenying Yang ◽

Krzysztof Strojek ◽

Sultan Linjawi

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Years Of Experience ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations

Turkish Journal of Endocrinology and Metabolism ◽

10.25179/tjem.2017-57420 ◽

2018 ◽

Vol 22 (3) ◽

pp. 183-197 ◽

Cited By ~ 1

Author(s):

Sema AKALIN ◽

Hasan AYDIN ◽

Mustafa Kemal BALCI ◽

Abdurrahman ÇÖMLEKÇİ ◽

Nevin DİNÇÇAĞ ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Expert Panel ◽

Diabetes Treatment ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Type 2 Diabetes Treatment